Induction of cytotoxic T-cell responses following oral immunization with synthetic peptides encapsulated in PLG microparticles

Journal of Controlled Release

Volumn 62, Issue 3, 1999, Pages 325-332

  Partidos, Charalambos D ^a   Vohra, Pramila ^b   Jones, David H ^c   Farrar, Graham ^c   Steward, Mike W ^b  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

CTL responses; Oral immunization; PLG microparticles

Indexed keywords

EPITOPE; POLYGLACTIN; SYNTHETIC PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CYTOTOXIC T LYMPHOCYTE; ENCAPSULATION; FEMALE; IMMUNIZATION; IN VITRO STUDY; LYMPHOCYTOTOXICITY; MICROPARTICLE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; SPLEEN CELL;

ADMINISTRATION, ORAL; AMINO ACID SEQUENCE; ANIMALS; CAPSULES; CHOLERA TOXIN; DRUG DELIVERY SYSTEMS; EPITOPES; FEMALE; IMMUNIZATION; MEASLES VIRUS; MICE; MICE, INBRED CBA; MOLECULAR SEQUENCE DATA; NUCLEOPROTEINS; PEPTIDES; POLYGLACTIN 910; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032832125     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(99)00157-1     Document Type: Article

References (35)

1. Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J. Clin. Immunol. 7:1987;731-737.
2. Chen S.C., Jones D.H., Fynan E.F., Farrar G.H., Clegg J.C.S., Greenberg H.B., Herrmann J.E. Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J. Virol. 72:(7):1998;5757-5761.
3. Jones D.H., McBride B.W., Thornton C., O'Hagan D.T., Robinson A., Farrar G.H. Orally administered microencaspulated Bordetella pertussis fimbriae protect mice from B. Pertussis respiratory infection. Inf. Immun. 64:(2):1996;489-494.
4. Marx P.A., Compans R.W., Gettie A., Staas J.K., Gilley R.M., Mulligan M.J., Yamshchikov G.V., Chen D., Eldridge J.H. Protection against vaginal SIV transmission with microencapsulated vaccine. Science. 260:1993;1323-1327.
5. Jones D.H., Corris S., McDonald S., Clegg J.C.S., Farrar G.H. Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine. 15:(8):1997;814-817.
6. Partidos C.D., Shaw D.M., Gander B., Merkle H.P., Howard C.R., Steward M.W. Induction of antibody responses to a synthetic peptide entrapped in biodegradable microparticles. Vaccine Research. 3:(4):1994;203-209.
7. Partidos C.D., Vohra P., Anagnostopoulou C., Jones D.H., Farrar G.H., W Steward M. Biodegradable microparticles as a delivery system for measles virus cytotoxic T cell epitopes. Mol. Immunol. 33:(6):1996;485-491.
8. Partidos C.D., Vohra P., Jones D.H., Farrar G.H., Steward M.W. Mucosal immunization with measles virus CTL epitopes encapsulated in biodegradable PLG microparticles. J. Immunol. Methods. 195:1996;135-138.
9. Redding T.W., Schally A.V., Tice T.R., Meyers W.E. Long acting delivery systems for peptides:Inhibition of rat prostate tymors by controlled release of D-Trp6-LH-RH from injectable microparticles. Proc. Natl. Acad. Sci. USA. 81:1984;5845-5848.
10. Miller R.A., Brady J.M., Cutwright D.E. Degradation rates of resorbable implants (polylactides and polyglycolides): rate modification with changes in PLA/PLGA copolymer ratios. J. Biomed. Mater. Res. 11:1977;711-719.
11. Eldridge J.H., Staas J.K., Meulbroek J.A., McGhee J.R., Tice T.R., Gilley R.M. Biodegradable microspheres as a vaccine delivery system. Mol. Immunol. 28:(3):1991;287-294.
12. Aguado M.T., Lambert P.H. Controlled release vaccines-biodegradable polylactide-polyglycolide (PL/PG) microspheres as antigen vehicles. Immunobiology. 184:1992;113-125.
13. Moore M.W., Carbone F.R., Bevan M.J. Processing and introduction of soluble protein into the class I pathway of antigen presentation. Cell. 54:1988;777-785.
14. Partidos C.D., Vohra P., Steward M.W. Priming of measles virus specific CTL responses after immunization with a CTL epitope linked to a fusogenic peptide. Virology. 215:1996;107-110.
15. Partidos C.D., Delmas A., Steward M.W. Structural requirements for synthetic immunogens to induce measles virus specific CTL responses. Mol. Immunology. 33:(16):1996;1223-1229.
16. Hsu S.C., Schadeck E.B., Delmas A., Shaw M., Steward M.W. Linkage to a fusion peptide to a CTL epitope from the nucleoprotein of measles virus enables incorporation into ISCOMs and induction of CTL responses following intranasal immunization. Vaccine. 14:(12):1996;1159-1166.
17. Levi R., Aboud-Pirak E., Leclerc C., Lowell G.H., Arnon R. Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes. Vaccine. 13:1995;1353-1359.
18. Layton G.T., Harris S.J., Myhan J., West D., Gotch F., Hill-Rrkins M., Cole J.S., Meyers N., Woodrow S., French T.J., Adamas S.E., Kingsman A.J. Induction of single and dual cytotoxic T-lymphocyte responses to viral proteins in mice using recombinant hybrid Ty-virus-like particles. Immunology. 87:1996;171-178.
19. Hsu S.-C., Obeid O.E., Collins M., Iqbal M., Chargeleque D., Steward M.W. Protective cytotoxic T lymphocyte responses against paramyxoviruses induced by epitope-based DNA vaccines:involvement of INF gamma. Intern. Immunol. 10:(10):1998;1441-1447.
20. Partidos C.D., Steward M.W. Prediction and identification of a T cell epitope in the fusion protein of measles virus immunodominant in mice and humans. J. Gen. Virol. 71:1990;2099-2105.
21. Eldridge J.H., Staas J.K., Meulbroek J.A., Tice T.R., Gilley R.M. Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Inf. Immun. 59:1991;2978-2986.
22. Rager Zisman B., Egan J.E., Kress Y., Bloom B.R. Isolation of cold-sensitive mutants of measles virus from persistently infected murine neuroblastoma cells. J. Virol. 51:1984;845-855.
23. Cardenas L., Clements J.D. Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens. Clin. Microbiol. Reviews. 5:(3):1992;328-343.
24. Etchart N., Wild F., Kaiserlian D. Mucosal and systemic immune responses to measles haemagglutinin in mice immunized with a recombinant vaccinia virus. J. Gen. Virol. 77:1996;2471-2478.
25. Strobel S., Mowat A. Immune responses to dietary antigens: oral tolerance. Immunol. Today. 19:(4):1998;173-181.
26. Moore A., McGuirk P., Adams S., Jones W.C., Paul McGee J., O'Hagan D., Mills K.H.G. Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells. Vaccine. 13:(18):1995;1741-1749.
27. Siebers A., Brett Finlay B. M cells and the pathogenesis of mucosal and systemic infections. Trends in Microbiology. 4:(1):1996;22-29.
28. Eldridge J.H., Hammond C.J., Meulbroek J.A., Staas J.K., Gilley R.M., Tice T.R. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches. J. Contr. Release. 11:1990;205-214.
29. Elson C.O. Kiyono H., Ogra P.L., McGhee J.R. Mucosal Vaccines. 1996;59-72 Academic Press, San Diego.
30. Gizurarson S., Tamura S.I., Aizawa C., Kurata T. Stimulation of the transepithelial flux of influenza HA vaccine by cholera toxin B subunit. Vaccine. 10:1992;101-106.
31. Davies M.D.J., Parrott D.M.V. Cytotoxic T cells in small intestine epithelial, lamina propria and lung lymphocytes. Immunology. 44:1981;367-371.
32. Yewdell J.W., Bennick J.R. The binary logic of antigen processing and presentation to T-cells. Cell. 62:1990;203-206.
33. Discoll J., Finley D. A controlled breakdown: antigen processing and the turnover of viral proteins. Cell. 68:1992;823-825.
34. Tabata Y., Ikada Y. Phagocytosis of polymer microspheres by macrophages. Adv. Polym. Sci. 94:1990;107-112.
35. Debrick J.E., Campbell P.A., Staerz U.D. Macrophages as accessory cells for class I MHC-restricted immune responses. J. Immunol. 147:1991;2846-2851.